Vulnerability in Bmc Remedy_mid-tier
CVE-2017-17677
BMC Remedy 9.1SP3 is affected by authenticated code execution. Authenticated users that have the right to create reports can use BIRT templates to run code.
EPSS: 0.013 (67.6th percentile) — read the EPSS interpretation.
CVSS v3 metric
CVSS v3 base score 8.8 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H.
Affected products
- Bmc Remedy_mid-tier — versions 9.1
- N/a — versions n/a
Weakness classification (CWE)
References
- cve@mitre.org (Product, x_refsource_MISC)
- cve@mitre.org (Product, x_refsource_MISC)
- cve@mitre.org (x_refsource_MISC, Release Notes, Vendor Advisory)
- cve@mitre.org (Mailing List, Third Party Advisory, x_refsource_MISC)
Frequently asked questions
- What is CVE-2017-17677?
- CVE-2017-17677 is a high-severity vulnerability in Bmc Remedy_mid-tier, classified under Incorrect Permission Assignment for Critical Resource. CVSS score: 8.8/10. Published 2021-05-19.
- How severe is CVE-2017-17677?
- High severity. CVSS v3 base score is 8.8 out of 10.